CURATED BY NIKI DE WITT
An experimental malaria vaccine, called PfSPZ, was recently tested on 15 volunteers and had hopeful results, protecting 12 of the participants. These findings are based on a small-scale trial, so the vaccine still needs many more tests before it hits the market. In about six weeks, Sanaria, the company that developed PfSPZ, will head to Africa to conduct a larger trial.
FROM NPR
A viable, effective vaccine against malaria has long eluded scientists. Results from a preliminary study have ignited hope that a new type of vaccine could change that.
The experimental vaccine offered strong protection against malaria when given at high doses, scientists report Thursday in the journal Science.
The study was extremely small and short-term. And the candidate vaccine still has a long way to go before it could be used in the developing world”….Continue Reading
Niki is currently exploring Asia while working on a children’s book series about travel. As a child, she traveled and moved often for her parents’ jobs. As a result of this, she has always felt most at home when she’s off and away. She is interested in international films, working on building an impressive tea collection, and can often be found with her camera in hand. You can have a look-see at her blog and follow her on Twitter @nikidding.
Photo by US Army Africa